Content about Niquitin

April 1, 2013
GSK Consumer Healthcare commends FDA nicotine replacement therapy proposals

GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

PARSIPPANY, N.J. — GlaxoSmithKline Consumer Healthcare today commended the proposals by the U.S. Food and Drug Administration after the administration announced recommendations to remove certain warning statements and modifications of the instructions for use of nicotine replacement therapy products.

According to the statement released by GSK Consumer Healthcare:

January 4, 2013
Mintel: Declining user base means smoking cessation aids will experience slow growth through 2017

Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported.

CHICAGO — Sales of smoking cessation aids are projected to reach $1 billion in 2012 with continued growth driving sales as high as $1.2 billion by 2017, market research firm Mintel reported Thursday. 

December 17, 2012
GSK to submit comments on FDA smoking-cessation products hearing

The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

PARSIPPANY, N.J. — The consumer products division of British drug maker GlaxoSmithKline wants its voice heard at a Food and Drug Administration hearing scheduled for next year on a section in a 2009 law to regulate tobacco products that deals with smoking-cessation products, the company said Monday.

December 11, 2012
GSK launches smoking-cessation site

The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

PARSIPPANY, N.J. — The consumer healthcare division of drug maker GlaxoSmithKline has launched a new website designed to encourage people to quit smoking and promote such products as nicotine gums, lozenges and patches.

Quit.com is described as a "total quit-smoking online resource" that includes features to help smokers create personalized plans for quitting without relapsing.

August 16, 2012
Report: Nicotine replacement product sales to reach $6.2 billion worldwide by 2018

Global sales of nicotine replacement products are expected to reach $6.2 billion in 2018, following compound annual growth rates of 4.5% between now and then, GBI Research reported Wednesday.

NEW YORK — Global sales of nicotine replacement products are expected to reach $6.2 billion in 2018, following compound annual growth rates of 4.5% between now and then, GBI Research reported Wednesday.

January 10, 2012
Harvard School survey asserts NRT ineffective in spite of body of evidence to the contrary

Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

BOSTON — Nicotine replacement therapies designed to help people stop smoking, specifically nicotine patches and nicotine gum, do not appear to be effective in helping smokers quit long-term, even when combined with smoking-cessation counseling, according to a new survey by researchers at Harvard School of Public Health and the University of Massachusetts Boston posted in an advance online edition of Tobacco Control Monday.

July 28, 2011
Study finds most smokers lack knowledge on ways to quit smoking

Almost half of all smokers try and fail to quit their addiction to nicotine products each year, according to a study released Wednesday.

PARSIPPANY, N.J. — Almost half of all smokers try and fail to quit their addiction to nicotine products each year, according to a study released Wednesday.

A contributing factor to the high rate of failed quit attempts is the low use of nicotine-replacement therapies, the study found. That may be because of misperceptions around the health effects of NRTs.

September 27, 2010
GSK Consumer Healthcare to FDA: Smoke out smokeless tobacco products

GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products...

PARSIPPANY, N.J. GlaxoSmithKline Consumer Healthcare is urging the Food and Drug Administration to remove smokeless tobacco products from the market.